Express Scripts Paid $250M for myMatrixx

Express Scripts did not disclose how much it paid for myMatrixx in public statements announcing the deal that closed in May, but the pharmacy benefit manager told the U.S. Securities and Exchange Commission the purchase price was around $250 million. St. Louis-based Express Scripts said in its 2nd quarter SEC filing submitted Wednesday that the acquisition of the PBM myMatrixx was not material to its consolidated financial statement. Express Scripts reported $25.3 billion in revenue during the second quarter of 2017, compared to $25.2 billion for the same period in 2016. It reported $50...